Filing Flows › Comparisons › EMMA vs VRCA
Emmaus Life Sciences vs Verrica Pharmaceuticals: EMMA and VRCA compared
Emmaus Life Sciences is the larger company: $6.3M of revenue in its latest quarter (Q2 2026) against $5.9M for Verrica Pharmaceuticals (Q2 2026). Emmaus Life Sciences is growing faster (+124% against -54% a year earlier). Emmaus Life Sciences is more profitable, with an operating margin of 60.0% against -223.4%.
Where the money goes: EMMA and VRCA
Emmaus Life Sciences (EMMA) · Q2 2026
Emmaus Life Sciences, Q2 2026: revenue $6.3M (+124% year over year), operating margin 60.0%, net earnings $1.3M, operating cash flow $1.7M. The chart follows the revenue to costs, profit and cash.
Verrica Pharmaceuticals (VRCA) · Q2 2026
Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
| Emmaus Life Sciences (EMMA) | Verrica Pharmaceuticals (VRCA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $6.3M | $5.9M |
| Revenue growth, Y/Y | +124% | -54% |
| Gross margin | 94.6% | — |
| Operating margin | 60.0% | -223.4% |
| Net earnings | $1.3M | −$13.2M |
| Net margin | 21.2% | -224.4% |
| Operating cash flow | $1.7M | −$9.3M |
Where the revenue comes from
Emmaus Life Sciences
- Endari US: $6.0M (95%)
- Endari International: $295K (5%)
- Product and Service Other: $22K (0%)
Questions
Which is bigger, Emmaus Life Sciences or Verrica Pharmaceuticals?
Emmaus Life Sciences is the larger company: $6.3M of revenue in its latest quarter (Q2 2026) against $5.9M for Verrica Pharmaceuticals (Q2 2026).
Is Emmaus Life Sciences or Verrica Pharmaceuticals growing faster?
Emmaus Life Sciences is growing faster (+124% against -54% a year earlier).
Which is more profitable, Emmaus Life Sciences or Verrica Pharmaceuticals?
Emmaus Life Sciences is more profitable, with an operating margin of 60.0% against -223.4%.
More: Emmaus Life Sciences earnings · how Emmaus Life Sciences makes money · Verrica Pharmaceuticals earnings · how Verrica Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 6, 2026). Fiscal quarters can end on different dates. Not investment advice.